Samsrita Labs Ltd. Stock price: Live updates

₹13.45

4.91% (0.63)

Market Cap

₹30 Cr.

P/E

0.00

Key Ratios

Edit Ratio's

Market cap

30.00 Cr

Prom Holding

25.44 %

ROE (%)

ROCE (%)

-2.14

Div Yield (%)

Sales

0.02 Cr

OPM (%)

-47,227 %

Debt to Equity

0.20

Institutions

Individual < 2 lac

3.25 %

No. of Shareholders

2,441

Edit Ratio's

About

Samsrita Labs is an integrated global Bio-pharmaceutical Company focusing on Stem Cell R&D and… Read more

Low

52W Range

High

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

Edit rows

Forensics

3 Yes

Positive for this company

2 Neutral

Neutral for this company

7 No

Negative for this company

4 No Data

Insufficient data to analyse

Accounting & Shareholding

Pledge

Promoters have not pledged a significant portion of their holding
Revenue Recognition

Company is converting accounting profit to cash
Promoter Holding

Promoter has not sold any shares in the last 90 days
Depreciation Effect

Company is depreciating a lower percentage of assets. this is contributing to an increase in net profit
Retail Holding

Retail has been buying the stock which is usually a sign of exuberance
Contingent Liabilities

Unable to calculate due to limited data
Other Income

Unable to calculate due to limited data

Price & Performance

Working Capital

Working capital of the company seems to be under control
Balance Sheet Strength

Balance sheet of the company is strong. but it might have issues paying it suppliers
Share price

Share price has decreased over last 10 years more due to earnings
Debt

Company might have issues servicing its debt
Sales Growth

Sales of the company has grown at a slow pace
Margin Stability

Margins of the company are volatile
ROCE Strength

Roce of the company is not consistently strong
Capex vs ROCE

Unable to calculate due to limited data
Current vs Historic Valuation

Unable to calculate due to limited data

Revenue mix

Product Wise Break-Up

Peer Comparison

FAQs on Samsrita Labs Ltd. Business

What does Samsrita Labs do?

Samsrita Labs is integrated global Bio-pharmaceutical Company. The company has been established as an advanced center for research and excellence in the areas of Stem Cell R&D and Therapy, New Drug discovery, Molecular Diagnostics, Stem cell based multi-Specialty Hospital and CRO.

Who are the competitors of Samsrita Labs?

Samsrita Labs major competitors are Franklin Industries, Medico Intercont., AG Universal, Supha Pharmachem, Shubhlaxmi Jewel Art, Prospect Consumer, Cell Point (India).
Market Cap of Samsrita Labs is ₹28 Crs.
While the median market cap of its peers are ₹28 Crs.

Is Samsrita Labs financially stable compared to its competitors?

Samsrita Labs seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

View FAQ's On Shareprice

Company Filing

	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary Powered by Claude

Discussions & Analysis

Ideas Dashboard

Results

Timeline

Watchlist

Portfolio

Alerts

Stock Screener

Market

Raw Material

Samsrita Labs Ltd.

Samsrita Labs Ltd.

Key Ratios

About

Timeline

Company Timeline

Custom financial statement

Forensics

3 Yes

2 Neutral

7 No

4 No Data

Accounting & Shareholding

Pledge

Revenue Recognition

Promoter Holding

Depreciation Effect

Retail Holding

Contingent Liabilities

Other Income

Price & Performance

Working Capital

Balance Sheet Strength

Share price

Debt

Sales Growth

Margin Stability

ROCE Strength

Capex vs ROCE

Current vs Historic Valuation

Revenue mix

Product Wise Break-Up

UNLOCK PREMIUM

Peer Comparison

FAQs on Samsrita Labs Ltd. Business

What does Samsrita Labs do?

Who are the competitors of Samsrita Labs?

Is Samsrita Labs financially stable compared to its competitors?

Company Filing

Discussions & Analysis

SIGN UP FOR FREE